Shan Ahmed Khan, Author at TechStock²

XRP pops again as U.S. spot ETF assets near $1.4B and buy pressure hits month-high

New York, January 5, 2026, 14:32 EST XRP rose about 9% to $2.27 on Monday after trading between $2.08 and $2.27, according to market data. The move is drawing attention to XRP-linked exchange-traded funds (ETFs), listed vehicles that track an

5 January 2026

Cryptocurrency·ETFs·Investment Trends·Market Analysis·XRP

BridgeBio Pharma (BBIO) stock sinks 7% as JPM conference nears and achondroplasia catalyst looms

New York, January 5, 2026, 14:30 (EST) — Regular session BridgeBio Pharma shares slid 7.5% to $72.34 in afternoon trading on Monday after opening at $78.44 and touching $79.24 earlier in the session. The drop outpaced a roughly 2.2% decline

5 January 2026

Biotechnology·Healthcare Industry·Investment Analysis·Pharma News·Stock Market

CNQ stock drops today as Venezuela turmoil dents Canadian Natural Resources shares

Toronto, Jan 5, 2026, 14:37 (ET) — Regular session Shares of Canadian Natural Resources Limited (CNQ.TO) (CNQ.N) fell 5.2% to $32.53 in New York afternoon trading on Monday as investors weighed the U.S. capture of Venezuelan President Nicolás Maduro. In

5 January 2026

Energy·Investing·Oil and Gas·Stock Market

Why Cenovus Energy stock is down today: Venezuela shock hits Canadian oil sands

Toronto, Jan 5, 2026, 14:19 (EST) — Regular session Cenovus Energy Inc shares fell more than 5% on Monday afternoon, tracking a selloff in Canadian oil sands producers as investors weighed whether Venezuela’s heavy crude could re-enter U.S. markets and

5 January 2026

Energy Sector·Investment News·Market Analysis·Stock Market

Fabrinet stock slides nearly 7% today as contract manufacturers sell off; earnings in focus

New York, Jan 5, 2026, 14:29 EST — Regular session Fabrinet (NYSE:FN) shares fell about 6.7% on Monday, bucking a rise in the broader market. The stock was down $32.06 at $447.36 by 2:29 p.m. EST, after swinging between $490.18

5 January 2026

Earnings Reports·Financial News·Investment·Stock Market

Sunrun stock slides as RUN lags solar peers with jobs report, Goldman conference in focus

New York, Jan 5, 2026, 14:26 EST — Regular session Sunrun Inc shares fell 5.6% on Monday, a sharp underperformer in U.S. solar, as investors weighed fresh U.S. economic data and looked ahead to a key jobs report later this

5 January 2026

Company News·Financial Reports·Investing·Stock Market

Viking Therapeutics stock sinks as Novo’s Wegovy pill debut resets obesity-drug pricing

New York, January 5, 2026, 14:21 EST — Regular session Shares of Viking Therapeutics (VKTX) slid 9.9% to $31.93 in afternoon trading on Monday as obesity-drug stocks reacted to Novo Nordisk’s U.S. launch of a Wegovy weight-loss pill. Novo’s U.S.-listed

5 January 2026

Drug Pricing·Health News·Pharmaceuticals·Stock Market

Wave Life Sciences stock drops 8% as JPM Healthcare Conference looms; obesity data in focus

New York, January 5, 2026, 1:09 PM ET — Regular session Wave Life Sciences Ltd shares fell $1.34, or 8.4%, to $14.61 in afternoon trade on Monday, extending a sharp pullback in the clinical-stage biotech even as the company flagged

5 January 2026

Biotech News·Healthcare Industry·Investment Analysis·Stock Market

Gulfport Energy stock (GPOR) slides nearly 9% on Wolfe downgrade as gas prices fall

New York, Jan 5, 2026, 13:05 EST — Regular session Gulfport Energy Corporation shares fell 8.7% on Monday after Wolfe Research analyst Carlos Escalante cut the U.S. gas producer to Peer Perform from Outperform. The stock traded at $188.26 after

5 January 2026

Analyst Ratings·Energy Sector·Investment·Natural Gas·Stock Market

SiTime stock slumps 9% after topping Wall Street targets, bucking chip rally

New York, Jan 5, 2026, 13:54 EST — Regular session SiTime Corp shares slid about 9% on Monday afternoon, reversing an earlier rise and wiping out a chunk of the timing-chip maker’s start-of-year gains. The Nasdaq-listed stock was down $33.46

5 January 2026

Earnings Reports·Investment·Semiconductors·Stock Market·Technology

Structure Therapeutics stock slides nearly 8% as Novo’s Wegovy pill debut jolts oral obesity-drug bets

NEW YORK, Jan 5, 2026, 13:54 EST — Regular session Structure Therapeutics shares fell 7.7% to $62.86 in afternoon trade on Monday, paring an earlier rally and marking another volatile session for the obesity-drug developer. The stock has ranged from

5 January 2026

Investment News·Pharmaceuticals·Stock Market

Astera Labs stock drops 8% after insider sale plan disclosed — what traders watch next

New York, Jan 5, 2026, 13:45 EST — Regular session Astera Labs shares fell 8.4% to $164.50 on Monday, after swinging from a session high near $185 to a low around $162.5. More than 5 million shares had traded by

5 January 2026

Financial News·Insider Trading·Investing·Stock Market·Trading Strategies